Literature DB >> 7805577

Functional aspects of creatine kinase in brain.

W Hemmer1, T Wallimann.   

Abstract

The distinct isoenzyme-specific localization of creatine kinase (CK) isoenzymes found recently in brain suggests an important function for CK in brain energetics and points to adaptation of the CK system to the special energy requirements of different neuronal and glial cell types. For example, the presence of brain-type B-CK in Bergmann glial cells and astrocytes is very likely related to the energy requirements for ion homeostasis (K(+)-resorption) in the brain, as well as for metabolite and neurotransmitter trafficking between glial cells and neurons. In contrast, the presence of muscle-type M-CK, found exclusively in Purkinje neurons which also express other muscle-specific proteins, is very likely related to the unique calcium metabolism of these neurons. In addition, the developmentally late appearance of mitochondrial CK (Mi-CK) during brain development indicates an important function for Mi-CK in the oxidative energy metabolism of the brain. The physiological importance of the phosphocreatine circuit fully operating in adult brain has been corroborated by recent data from in vivo 31P-NMR magnetization transfer measurements. Future investigations should concentrate on the possible involvement of CK in diseases of the CNS with altered energy metabolism, aspects of which are also discussed here.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7805577     DOI: 10.1159/000111342

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  34 in total

1.  Arginine kinase expression and localization in growth cone migration.

Authors:  Y E Wang; P Esbensen; D Bentley
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

2.  Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry.

Authors:  Robert Cunningham; Paige Jany; Albee Messing; Lingjun Li
Journal:  J Proteome Res       Date:  2013-01-11       Impact factor: 4.466

3.  A new multistep induction protocol for the transdifferentiation of bone marrow stromal stem cells into GABAergic neuron-like cells.

Authors:  Shahram Darabi; Taki Tiraihi; AliReza Delshad; Majid Sadeghizadeh
Journal:  Iran Biomed J       Date:  2013

Review 4.  Creatine kinase in non-muscle tissues and cells.

Authors:  T Wallimann; W Hemmer
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

5.  Proline reduces creatine kinase activity in the brain cortex of rats.

Authors:  Adriana Kessler; Elisa Costabeber; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

6.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

7.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

8.  Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes.

Authors:  B Bindukumar; S D Mahajan; J L Reynolds; Z Hu; D E Sykes; R Aalinkeel; S A Schwartz
Journal:  Brain Res       Date:  2007-11-01       Impact factor: 3.252

9.  Inhibition of mitochondrial creatine kinase activity by D-2-hydroxyglutaric acid in cerebellum of young rats.

Authors:  Cleide G da Silva; Ana Rubia F Bueno; Rafael B Rosa; Carlos S Dutra Filho; Clovis M D Wannmacher; Angela T S Wyse; Moacir Wajner
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

10.  Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Lichuan Yang; Kimberly L Ferrante; Steven M Hersch; M Flint Beal; Robert J Ferrante
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.